David E. Moody

6.9k total citations
192 papers, 5.5k citations indexed

About

David E. Moody is a scholar working on Molecular Biology, Pharmacology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, David E. Moody has authored 192 papers receiving a total of 5.5k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 58 papers in Pharmacology and 46 papers in Public Health, Environmental and Occupational Health. Recurrent topics in David E. Moody's work include Pharmacogenetics and Drug Metabolism (54 papers), Opioid Use Disorder Treatment (44 papers) and Forensic Toxicology and Drug Analysis (31 papers). David E. Moody is often cited by papers focused on Pharmacogenetics and Drug Metabolism (54 papers), Opioid Use Disorder Treatment (44 papers) and Forensic Toxicology and Drug Analysis (31 papers). David E. Moody collaborates with scholars based in United States, Venezuela and Austria. David E. Moody's co-authors include Janardan K. Reddy, Elinore F. McCance‐Katz, R. L. Foltz, Bruce D. Hammock, Edward A. Smuckler, Wenfang B. Fang, David M. Andrenyak, J K Reddy, Wei Huang and Yan Chang and has published in prestigious journals such as The Journal of Cell Biology, Journal of the American College of Cardiology and Analytical Chemistry.

In The Last Decade

David E. Moody

188 papers receiving 5.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David E. Moody United States	41	1.5k	1.3k	1.1k	779	740	192	5.5k
Felix Bochner Australia	42	710 0.5×	674 0.5×	1.3k 1.2×	1.1k 1.4×	291 0.4×	162	5.3k
Barry Levine United States	43	1.0k 0.7×	1.0k 0.7×	561 0.5×	378 0.5×	2.0k 2.7×	195	5.8k
Chin B. Eap Switzerland	51	1.4k 0.9×	944 0.7×	2.5k 2.3×	1.9k 2.4×	406 0.5×	288	9.2k
Andrew A. Somogyi Australia	50	1.3k 0.8×	1.1k 0.8×	2.1k 1.9×	1.7k 2.2×	296 0.4×	253	9.1k
Johan Ahlner Sweden	41	512 0.3×	613 0.5×	549 0.5×	385 0.5×	1.0k 1.4×	171	4.9k
C. Lindsay DeVane United States	46	682 0.5×	565 0.4×	1.2k 1.1×	1.2k 1.5×	267 0.4×	158	5.8k
Gail D. Anderson United States	43	867 0.6×	763 0.6×	762 0.7×	2.0k 2.6×	106 0.1×	109	6.0k
Peter Jatlow United States	48	1.5k 1.0×	612 0.5×	301 0.3×	546 0.7×	900 1.2×	161	6.6k
David Foster Australia	31	1.2k 0.8×	421 0.3×	438 0.4×	525 0.7×	120 0.2×	109	4.0k
Frank Mußhoff Germany	42	1.2k 0.8×	351 0.3×	506 0.5×	365 0.5×	2.9k 3.9×	240	6.5k

Countries citing papers authored by David E. Moody

Since Specialization

Citations

This map shows the geographic impact of David E. Moody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Moody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Moody more than expected).

Fields of papers citing papers by David E. Moody

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Moody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Moody. The network helps show where David E. Moody may publish in the future.

Co-authorship network of co-authors of David E. Moody

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Moody. A scholar is included among the top collaborators of David E. Moody based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Moody. David E. Moody is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hicks, Martin J., Stephen M. Kaminsky, Bishnu P. De, et al.. (2014). Fate of Systemically Administered Cocaine in Nonhuman Primates Treated with the dAd5GNE Anticocaine Vaccine. PubMed. 25(1). 40–49. 28 indexed citations

Bruce, R. Douglas, David E. Moody, Frederick L. Altice, Marc N. Gourevitch, & Gerald Friedland. (2013). A review of pharmacological interactions between HIV or hepatitis C virus medications and opioid agonist therapy: implications and management for clinical practice. Expert Review of Clinical Pharmacology. 6(3). 249–269. 40 indexed citations

Moody, David E., et al.. (2011). Gender differences in pharmacokinetics of maintenance dosed buprenorphine. Drug and Alcohol Dependence. 118(2-3). 479–483. 56 indexed citations

Bruce, R. Douglas, Frederick L. Altice, David E. Moody, et al.. (2009). Pharmacokinetic interactions between buprenorphine/naloxone and tipranavir/ritonavir in HIV-negative subjects chronically receiving buprenorphine/naloxone. Drug and Alcohol Dependence. 105(3). 234–239. 18 indexed citations

Greenwald, Mark K., Chris‐Ellyn Johanson, Joshua A. Bueller, et al.. (2006). Buprenorphine Duration of Action: Mu-opioid Receptor Availability and Pharmacokinetic and Behavioral Indices. Biological Psychiatry. 61(1). 101–110. 93 indexed citations

McCance‐Katz, Elinore F., David E. Moody, Gene D. Morse, et al.. (2006). Interactions between Buprenorphine and Antiretrovirals. I. The Nonnucleoside Reverse-Transcriptase Inhibitors Efavirenz and Delavirdine. Clinical Infectious Diseases. 43(Supplement_4). S224–S234. 66 indexed citations

Chen, Mingli, David M. Andrenyak, David E. Moody, & R. L. Foltz. (2005). Determination of riboflavin by high-performance liquid chromatography with riboflavin-depleted urine as calibration and control matrix. Journal of Chromatography B. 820(1). 147–150. 19 indexed citations

Reilly, Christopher A., William J. Ehlhardt, David A. Jackson, et al.. (2003). Metabolism of Capsaicin by Cytochrome P450 Produces Novel Dehydrogenated Metabolites and Decreases Cytotoxicity to Lung and Liver Cells. Chemical Research in Toxicology. 16(3). 336–349. 107 indexed citations

Borg, Lisa, Ann Ho, Aaron Wells, et al.. (2002). The Use of Levo-Alpha-Acetylmethadol (LAAM) in Methadone Patients Who Have Not Achieved Heroin Abstinence. Journal of Addictive Diseases. 21(3). 13–22. 4 indexed citations

10.

Foltz, Rodger L., et al.. (1997). Comparison of Immunoassays for Semi-quantitative Measurement of Benzoylecgonine in Urine. PsycEXTRA Dataset. 175. 287–302. 1 indexed citations

11.

Slawson, Matthew H., Michael R. Franklin, & David E. Moody. (1996). Correlations of the induction of microsomal epoxide hydrolase activity with phase II drug conjugating enzyme activities in rat liver. Toxicology Letters. 85(1). 29–34. 10 indexed citations

12.

Crouch, Dennis J., et al.. (1995). Analysis of Cocaine and Its Metabolites from Biological Specimens Using Solid-Phase Extraction and Positive Ion Chemical Ionization Mass Spectrometry. Journal of Analytical Toxicology. 19(6). 352–358. 33 indexed citations

13.

Moody, David E.. (1994). Peroxisome proliferators : unique inducers of drug-metabolizing enzymes. CRC Press eBooks. 28 indexed citations

14.

Ho, John & David E. Moody. (1993). Determination of tolbutamide hydroxylation in rat liver microsomes by high-performance liquid chromatography: Effect of psychoactive drugs on in vitro activity. Life Sciences. 52(1). 21–28. 14 indexed citations

15.

Ho, John & David E. Moody. (1992). Gas chromatography/mass spectrometry assays for the determination of debrisoquine and sparteine metabolites in microsomal fractions of rat liver. Analytical Biochemistry. 203(2). 348–351. 2 indexed citations

16.

Moody, David E., Gary A. Clawson, C. H. Woo, & Edward A. Smuckler. (1981). Cytochrome P-450 lowering effect of 1,2-dibromo-3-chloropropane and carbon tetrachloride. Federation Proceedings. 40. 1 indexed citations

17.

Moody, David E., et al.. (1980). Cytochrome P-450 lowering effect of alkyl halides, correlation with decrease in arachidonic acid. Biochemical and Biophysical Research Communications. 97(2). 673–679. 5 indexed citations

18.

Moody, David E. & Janardan K. Reddy. (1978). Hepatic peroxisome (microbody) proliferation in rats fed plasticizers and related compounds. Toxicology and Applied Pharmacology. 45(2). 497–504. 191 indexed citations

19.

Moody, David E. & Janardan K. Reddy. (1976). Comparative effects of hypolipidemic drugs on hepatic peroxisomal enzymes. 35(3). 1 indexed citations

20.

Moody, David E. & Janardan K. Reddy. (1975). Morphometric analysis of ultrastructural changes in rat liver induced by peroxisome proliferators. Journal of Histochemistry & Cytochemistry. 23(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact